Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioDrug is a South Korean biotechnology company specializing in the development of advanced drug delivery systems, particularly focused on Transdermal Drug Delivery Systems (TDDS). The company leverages its proprietary platform to convert oral or injectable medications into convenient skin patches, aiming to improve patient compliance and therapeutic efficacy. Their primary research focus includes treatments for neurodegenerative diseases such as Parkinson's and Alzheimer's, as well as metabolic disorders like diabetes and obesity. By optimizing the delivery of peptides and small molecules through the skin, BioDrug seeks to provide stable drug concentrations and reduce side effects associated with traditional administration routes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIODRUG.